ROSE HILLS CO
10-Q, EX-27, 2000-11-14
PERSONAL SERVICES
Previous: ROSE HILLS CO, 10-Q, 2000-11-14
Next: BIONX IMPLANTS INC, 10-Q, 2000-11-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
unaudited interim consolidated financial statements of Rose Hills Company and
subsidiaries, for the nine months ended September 30, 2000 and is qualified in
its entirety by reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                           9,279
<SECURITIES>                                         0
<RECEIVABLES>                                   12,500
<ALLOWANCES>                                         0
<INVENTORY>                                      1,175
<CURRENT-ASSETS>                                30,080
<PP&E>                                          59,602
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 314,725
<CURRENT-LIABILITIES>                           17,424
<BONDS>                                         80,000
                                0
                                          0
<COMMON>                                             0
<OTHER-SE>                                     131,268
<TOTAL-LIABILITY-AND-EQUITY>                   314,725
<SALES>                                         61,000
<TOTAL-REVENUES>                                61,000
<CGS>                                           40,834
<TOTAL-COSTS>                                   40,834
<OTHER-EXPENSES>                                 8,449
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              11,720
<INCOME-PRETAX>                                     (3)
<INCOME-TAX>                                       718
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                      (721)
<EPS-BASIC>                                          0
<EPS-DILUTED>                                        0


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission